1.75
price up icon2.34%   0.04
after-market Handel nachbörslich: 1.75
loading

Inhibikase Therapeutics Inc Aktie (IKT) Neueste Nachrichten

pulisher
02:01 AM

What moving averages say about Inhibikase Therapeutics Inc.Chart Signals & Verified Short-Term Plans - Newser

02:01 AM
pulisher
06:56 AM

Inhibikase Therapeutics: Is the GAAP EPS Loss a Short-Term Hurdle or a Warning Sign? - AInvest

06:56 AM
pulisher
05:04 AM

Inhibikase Posts Wider Loss in Q2 - AOL.com

05:04 AM
pulisher
03:35 AM

Visual analytics tools that track Inhibikase Therapeutics Inc. performanceMarket Weekly Review & Weekly Chart Analysis and Trade Guides - Newser

03:35 AM
pulisher
01:45 AM

Inhibikase Therapeutics Reports Q2 2025 Financials and Progress - TipRanks

01:45 AM
pulisher
12:18 PM

How institutional ownership impacts Inhibikase Therapeutics Inc. stockMarket Sentiment Summary & Long-Term Safe Investment Ideas - Newser

12:18 PM
pulisher
12:02 PM

Visual trend scoring systems applied to Inhibikase Therapeutics Inc.July 2025 Selloffs & AI Forecast for Swing Trade Picks - Newser

12:02 PM
pulisher
Aug 14, 2025

Trend Reversal Possible in Inhibikase Therapeutics Inc. Charts IndicateJuly 2025 Closing Moves & Verified Swing Trading Watchlists - sundaytimes.kr

Aug 14, 2025
pulisher
Aug 14, 2025

Inhibikase Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 14, 2025
pulisher
Aug 14, 2025

Inhibikase Therapeutics Reports Q2 2025 Financial Results - TipRanks

Aug 14, 2025
pulisher
Aug 14, 2025

Inhibikase Therapeutics Announces Second Quarter 2025 Financial Results and Highlights Recent Activity | IKT Stock News - GuruFocus

Aug 14, 2025
pulisher
Aug 14, 2025

Inhibikase Therapeutics, Inc. SEC 10-Q Report - TradingView

Aug 14, 2025
pulisher
Aug 14, 2025

Inhibikase Therapeutics Announces Second Quarter 2025 Financial Results and Highlights Recent Activity - The Manila Times

Aug 14, 2025
pulisher
Aug 14, 2025

Inhibikase's PAH Drug Advances to Phase 2b Trial With Promising Efficacy Target in Pulmonary Disease - Stock Titan

Aug 14, 2025
pulisher
Aug 14, 2025

What makes Inhibikase Therapeutics Inc. stock price move sharplyJuly 2025 Patterns & Reliable Momentum Entry Alerts - Newser

Aug 14, 2025
pulisher
Aug 13, 2025

Chart based analysis of Inhibikase Therapeutics Inc. trendsWeekly Gains Report & AI Powered Market Trend Analysis - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Using fundamentals and technicals on Inhibikase Therapeutics Inc.Weekly Stock Summary & Risk Adjusted Buy and Sell Alerts - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Automated trading signals detected on Inhibikase Therapeutics Inc.Portfolio Return Report & Accurate Buy Signal Notifications - Newser

Aug 13, 2025
pulisher
Aug 12, 2025

Real time pattern detection on Inhibikase Therapeutics Inc. stockBollinger Band Squeeze and Expansion Analysis - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Blair William & Co. IL Has $342,000 Stake in Inhibikase Therapeutics, Inc. (NYSE:IKT) - Defense World

Aug 12, 2025
pulisher
Aug 12, 2025

New Product Launches: Will They Boost Inhibikase Therapeutics Inc. Stock in 2025Free Watchlist for Smart Swing Trading - Newser

Aug 12, 2025
pulisher
Aug 11, 2025

Key metrics from Inhibikase Therapeutics Inc.’s quarterly dataSwing Watchlist With Tight Stop Placement - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

What indicators show strength in Inhibikase Therapeutics Inc.Free Real Market Momentum Signal Generator - Newser

Aug 11, 2025
pulisher
Aug 09, 2025

How high can Inhibikase Therapeutics Inc. stock goMonthly Long-Term Market Recap and Summary - Newser

Aug 09, 2025
pulisher
Aug 09, 2025

Risk vs reward if holding onto Inhibikase Therapeutics Inc.Tactical Trade Setup With Entry Optimizer - Newser

Aug 09, 2025
pulisher
Aug 08, 2025

Inhibikase Therapeutics Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView

Aug 08, 2025
pulisher
Aug 08, 2025

What risks could impact Inhibikase Therapeutics Inc. stock performanceFree Weekly Potential Breakout Stock List - Newser

Aug 08, 2025
pulisher
Aug 08, 2025

Inhibikase Therapeutics Inc. recovery potential after sell offSmart Risk Strategy with Entry Optimization - Newser

Aug 08, 2025
pulisher
Aug 07, 2025

How Inhibikase Therapeutics Inc. stock performs during market volatilitySafe Entry Screening with Data Backed Analysis - Newser

Aug 07, 2025
pulisher
Aug 06, 2025

Published on: 2025-08-06 00:58:01 - Newser

Aug 06, 2025
pulisher
Aug 04, 2025

Published on: 2025-08-04 16:30:58 - metal.it

Aug 04, 2025
$36.35
price down icon 0.41%
$86.92
price up icon 0.88%
$26.69
price up icon 0.91%
$127.80
price up icon 0.04%
$113.52
price up icon 0.73%
biotechnology ONC
$321.36
price up icon 3.77%
Kapitalisierung:     |  Volumen (24h):